The Patient Service Specialist II (Contractor) supports Duchenne Muscular Dystrophy patients and families as a member of the Patient Services Team. Paired with a Case Manger(s), the Patient Service Specialist II supports the team through data updates to patient records, tracking case status, set-up of new patient referrals and patient outreach. The Patient Service Specialist II will learn and master all skills of Case Management. Primary Responsibilities Include: Provides patient intake support (checks documents, enters patient data to CRM and attaches appropriate documents to patient case) Works with Case Managers and Senior Case Managers to initiate patient outreach. Participate in a structured case management/reimbursement training led by teammates and demonstrate learned skills. Acts as a backup/floater to the case management team as necessary. Supports SareptAssist telephone line by handling incoming communications. Understands and adheres to Sarepta Compliance/HIPPA regulations in every aspect of the job. Position may require some travel. Desired Education and Skills: BA/BS preferred or HS diploma with relevant experience in rare disease. 3 years of case management experience in a related field preferred. Strong computer skills including knowledge of Microsoft Office Suite Strong listening, verbal, and written communication skills Highly interested in supporting patients and families Must enjoy working in a fast-paced, innovative environment. Must be flexible, proactive, friendly, empathetic, efficient, and a team player. Embraces continuous learning/seeks knowledge. Thrive as a self-starter who proactively senses and responds to problems and opportunities; able and willing to learn and react quickly. #LI-Hybrid This position requires work on site at one of Sarepta’s facilities in the United States. Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.